Mitochondrial Ultrastructure and Activity Are Differentially Regulated by Glycolysis-, Krebs Cycle-, and Microbiota-Derived Metabolites in Monocytes.
Krebs cycle
glycolysis
innate immunity
mitochondria
mitochondrial reprogramming
short-chain fatty acids
Journal
Biology
ISSN: 2079-7737
Titre abrégé: Biology (Basel)
Pays: Switzerland
ID NLM: 101587988
Informations de publication
Date de publication:
28 Jul 2022
28 Jul 2022
Historique:
received:
08
06
2022
revised:
15
07
2022
accepted:
16
07
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
Several intermediate metabolites harbour cell-signalling properties, thus, it is likely that specific metabolites enable the communication between neighbouring cells, as well as between host cells with the microbiota, pathogens, and tumour cells. Mitochondria, a source of intermediate metabolites, participate in a wide array of biological processes beyond that of ATP production, such as intracellular calcium homeostasis, cell signalling, apoptosis, regulation of immune responses, and host cell-microbiota crosstalk. In this regard, mitochondria's plasticity allows them to adapt their bioenergetics status to intra- and extra-cellular cues, and the mechanisms driving such plasticity are currently a matter of intensive research. Here, we addressed whether mitochondrial ultrastructure and activity are differentially shaped when human monocytes are exposed to an exogenous source of lactate (derived from glycolysis), succinate, and fumarate (Krebs cycle metabolic intermediates), or butyrate and acetate (short-chain fatty acids produced by intestinal microbiota). It has previously been shown that fumarate induces mitochondrial fusion, increases the mitochondrial membrane potential (Δψ
Identifiants
pubmed: 36009759
pii: biology11081132
doi: 10.3390/biology11081132
pmc: PMC9404980
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Medical Research Council
ID : MR/R005850/1
Pays : United Kingdom
Organisme : Consejo Nacional de Ciencia y Tecnología (CONACYT)
ID : 284602
Organisme : GCRF Networks in Vaccines Research and Development VALIDATE Network
ID : P020
Organisme : SIP-IPN
ID : 20201688
Déclaration de conflit d'intérêts
The authors declare no competing interests.
Références
J Biol Chem. 2003 Mar 28;278(13):11312-9
pubmed: 12496283
EMBO J. 2019 Nov 15;38(22):e101056
pubmed: 31609012
FEBS Lett. 2013 Aug 2;587(15):2399-404
pubmed: 23770096
Oncotarget. 2016 Aug 30;7(35):56071-56082
pubmed: 27528227
J Clin Invest. 2010 Aug;120(8):2910-9
pubmed: 20664170
Prostaglandins Leukot Essent Fatty Acids. 2006 Sep;75(3):149-59
pubmed: 16829065
Front Immunol. 2014 Sep 02;5:420
pubmed: 25228902
J Physiol. 2012 Jul 15;590(14):3349-60
pubmed: 22586215
J Biol Chem. 2005 Jul 22;280(29):26649-52
pubmed: 15929991
Biochem Biophys Res Commun. 2008 Dec 19;377(3):987-91
pubmed: 18952058
J Lipid Res. 2016 Jun;57(6):943-54
pubmed: 27080715
Diabetes. 2017 May;66(5):1405-1418
pubmed: 28223285
J Bioenerg Biomembr. 1978 Apr;10(1-2):23-44
pubmed: 45333
Cell Res. 2020 Jun;30(6):492-506
pubmed: 32433595
Cell Signal. 2020 Oct;74:109717
pubmed: 32711109
Int Immunopharmacol. 2017 Oct;51:47-56
pubmed: 28802151
Endocrinology. 2016 May;157(5):1881-94
pubmed: 26990063
Cell. 2018 Aug 9;174(4):780-784
pubmed: 30096309
J Appl Physiol (1985). 2013 Jan 15;114(2):161-71
pubmed: 23104694
Nature. 2013 Apr 11;496(7444):238-42
pubmed: 23535595
Curr Protoc Stem Cell Biol. 2018 Nov;47(1):e67
pubmed: 30303625
Nat Commun. 2020 Jan 3;11(1):102
pubmed: 31900386
Transl Psychiatry. 2018 Feb 2;8(1):42
pubmed: 29391397
FASEB J. 2020 Oct;34(10):13091-13105
pubmed: 32812686
Cell Death Dis. 2018 Jun 4;9(6):672
pubmed: 29867110
Front Oncol. 2020 Oct 16;10:574787
pubmed: 33178603
Hum Mol Genet. 2017 Aug 1;26(15):2864-2873
pubmed: 28460056
Acta Biochim Pol. 2019 Mar 4;66(1):1-12
pubmed: 30831575
Front Cardiovasc Med. 2022 Jul 11;9:915102
pubmed: 35898266
Nat Immunol. 2017 Apr 18;18(5):488-498
pubmed: 28418387
Biochem Biophys Res Commun. 2018 May 27;500(1):94-101
pubmed: 28438601
Biochim Biophys Acta Mol Basis Dis. 2017 Sep;1863(9):2307-2318
pubmed: 28634116
Front Immunol. 2018 Jul 12;9:1605
pubmed: 30050539
Front Immunol. 2016 Feb 16;7:52
pubmed: 26909082
FASEB J. 2013 Nov;27(11):4366-74
pubmed: 23882124
Cell Metab. 2016 Dec 13;24(6):807-819
pubmed: 27866838
J Exp Med. 2016 Aug 22;213(9):1655-62
pubmed: 27481132
J Clin Invest. 2019 Feb 1;129(2):631-646
pubmed: 30431439
Essays Biochem. 2018 Jul 20;62(3):341-360
pubmed: 30030364
Exp Cell Res. 2020 Mar 15;388(2):111846
pubmed: 31945319
Nat Rev Mol Cell Biol. 2012 Sep;13(9):566-78
pubmed: 22850819
Nat Metab. 2019 Jan;1:16-33
pubmed: 31032474
Adv Exp Med Biol. 2012;748:13-40
pubmed: 22729853
Cell Res. 2015 Jul;25(7):771-84
pubmed: 26045163
PLoS One. 2020 Sep 30;15(9):e0239428
pubmed: 32997697
Trends Immunol. 2017 Jun;38(6):395-406
pubmed: 28396078
Elife. 2019 Jan 29;8:
pubmed: 30694178
Front Immunol. 2020 Aug 05;11:1715
pubmed: 32849605
Biomark Res. 2021 Jan 6;9(1):1
pubmed: 33407885
Biochim Biophys Acta. 2009 Jan;1793(1):5-19
pubmed: 18620004
Biochem Biophys Res Commun. 2008 Oct 31;375(4):562-5
pubmed: 18722346
Interface Focus. 2017 Apr 6;7(2):20160100
pubmed: 28382199
Front Oncol. 2020 Mar 18;10:231
pubmed: 32257942
J Lipid Res. 2013 Sep;54(9):2325-40
pubmed: 23821742
Int J Mol Sci. 2020 Feb 24;21(4):
pubmed: 32102422
Trends Biochem Sci. 2016 Mar;41(3):261-273
pubmed: 26857402
J Biol Chem. 2015 Jan 2;290(1):46-55
pubmed: 25406319
Cold Spring Harb Perspect Biol. 2019 Oct 1;11(10):
pubmed: 31110132
Front Endocrinol (Lausanne). 2020 Jun 11;11:374
pubmed: 32595603
Annu Rev Pathol. 2020 Jan 24;15:235-259
pubmed: 31585519
BMC Physiol. 2014 Dec 09;14:12
pubmed: 25488103
Sci Rep. 2017 Oct 12;7(1):13101
pubmed: 29026134
Cell Metab. 2019 Dec 3;30(6):1055-1074.e8
pubmed: 31708446
Cell. 2016 Oct 6;167(2):457-470.e13
pubmed: 27667687
Nutrients. 2011 Oct;3(10):858-76
pubmed: 22254083
Front Cell Dev Biol. 2020 Feb 07;8:51
pubmed: 32117978